- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04999982
Pilot Testing PREschooler Care, Community Resources, Advocacy, Referral, Education (PRE-CARE) (PRE-CARE)
Pilot Testing PRE-CARE to Address Unmet Social Needs for Preschoolers With Inattention and/or Hyperactivity
The goal of this proposed study is to pilot test a novel treatment model (PRE-CARE) addressing unmet social needs for families of preschool-age children with Attention Deficit/Hyperactivity Disorder (ADHD) symptoms. The investigators will conduct an adaptive, pilot randomized controlled trial (RCT) of the intervention with parents of 60 low-income children age 3-5 (36-71 months) with ADHD symptoms in order to: optimize intervention delivery; field test study logistics (e.g., recruitment, enrollment, randomization, retention); explore putative intervention mechanisms; and obtain estimates of study parameters to plan an appropriately powered RCT of the intervention.
The PRE-CARE intervention is adapted from Well Child Care, Evaluation, Community, Resources, Advocacy, Referral, Education (WE CARE), a screening and referral intervention that has been shown to be feasible and effective in addressing the family psychosocial stressors of low-income families seen in pediatric medical homes. Given the negative impact that socioeconomic stressors can have on the health and development of young children with ADHD symptoms, tailored interventions such as PRE-CARE may serve as a vital early intervention strategy to promote long-term well-being.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Andrea Spencer, MD
- Phone Number: 617-414-1932
- Email: andrea.spencer@bmc.org
Study Contact Backup
- Name: Jennifer Sikov, MA
- Phone Number: 617-638-8541
- Email: jennifer.sikov@bmc.org
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Boston Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Legal guardian and primary caregiver of a child aged 36-71 months
- Legal guardian or primary caregiver is age 16 years or older
- Child receives pediatric care at Boston Medical Center or at one of the participating Boston HealthNet clinics
- Able to understand informed consent procedures in English or Spanish
Participant has a child aged 36-71 months with an ADHD diagnosis, OR one elevated total or subscale score at the 80th percentile on the ADHD-Rating Scale-IV Preschool Version. 80th percentile cut-offs on the ADHD-Rating Scale-IV Preschool Version are as follows:
- For male children, a total score ≥ 25 OR subscale score (inattention and/or hyperactivity) ≥ 12
- For female children, a total score ≥ 13 OR subscale score (inattention and/or hyperactivity) ≥ 6 for female children
Exclusion Criteria:
- There are no specific exclusion criteria for this study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group- PRE-CARE
Participants will receive the 1:1 PRE-CARE social needs navigation intervention with specific content and delivery strategy which was developed based on 1) quantitative analyses of the association between unmet social needs and ADHD symptoms in a large-scale nationally representative sample of children age 3-5, and 2) in-depth qualitative interviews with parents/guardians of preschoolers with inattention and/or hyperactivity symptoms to identify mechanisms by which unmet social needs exacerbate ADHD symptoms and functioning.
|
Parent-report screening for remediable, unmet social needs.
Provision of packet of resource sheets ("Family Resource Booklet") detailing local community-based resources to address these needs, with needs that respond to family's requests highlighted.
Navigation to resources, care coordination, and parent support provided by a trained bachelors-level interventionist.
|
Active Comparator: Control group- Care as Usual
Families randomly assigned to the control condition will continue to receive care as usual, which includes screening for social needs annually at well-child visits as recommended by the American Academy of Pediatrics (AAP), followed by provision of information as needed by the family.
Families will also be offered the opportunity to make research assessments available to their primary care physician for best continuity of care.
|
Screening for social needs annually at well-child visits as recommended by the AAP followed by provision of information as needed by the family.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ADHD Symptoms at baseline
Time Frame: Baseline
|
ADHD-Rating Scale (RS)-IV Preschool Version will be used to assess ADHD Symptoms.
The 18 item scale consists of 2 subscales: inattention (9 items) and hyperactivity-impulsivity (9 items).
Responses for each item can be 0 to 3 where 0= rarely or never and 3= Very often.
Each subscale can have a range of 0 to 27 with higher scores correlated with more frequent symptoms.
|
Baseline
|
ADHD Symptoms at 3 months
Time Frame: 3 months
|
ADHD-Rating Scale (RS)-IV Preschool Version will be used to assess ADHD Symptoms.
The 18 item scale consists of 2 subscales: inattention (9 items) and hyperactivity-impulsivity (9 items).
Responses for each item can be 0 to 3 where 0= rarely or never and 3= Very often.
Each sub-scale can have a range of 0 to 27 with higher scores correlated with more frequent symptoms.
|
3 months
|
ADHD Symptoms at 6 months
Time Frame: 6 months
|
ADHD-Rating Scale (RS)-IV Preschool Version will be used to assess ADHD Symptoms.
The 18 item scale consists of 2 subscales: inattention (9 items) and hyperactivity-impulsivity (9 items).
Responses for each item can be 0 to 3 where 0= rarely or never and 3= Very often.
Each subscale can have a range of 0 to 27 with higher scores correlated with more frequent symptoms.
|
6 months
|
ADHD Symptoms at 12 months
Time Frame: 12 months
|
ADHD-Rating Scale (RS)-IV Preschool Version will be used to assess ADHD Symptoms.
The 18 item scale consists of 2 subscales: inattention (9 items) and hyperactivity-impulsivity (9 items).
Responses for each item can be 0 to 3 where 0= rarely or never and 3= Very often.
Each subscale can have a range of 0 to 27 with higher scores correlated with more frequent symptoms.
|
12 months
|
Child Psychiatric Symptoms at baseline
Time Frame: Baseline
|
The Child Behavior Checklist 1.5-5 (CBCL 1.5/5) will be used to assess child psychiatric symptoms which obtains caregivers' ratings of 99 problem items.
Items are scored on the following syndrome scales: Emotionally Reactive, Anxious/Depressed, Somatic Complaints, Withdrawn, Attention Problems, Aggressive Behavior, and Sleep Problems.
Parents/caregivers rate each item 0=not true, 1=somewhat or sometimes true, 2=very true or often true of the child (based on the preceding two months).
Higher scores are correlated with more psychiatric symptoms.
|
Baseline
|
Child Psychiatric Symptoms at 3 months
Time Frame: 3 months
|
The Child Behavior Checklist 1.5-5 (CBCL 1.5/5) will be used to assess child psychiatric symptoms which obtains caregivers' ratings of 99 problem items.
Items are scored on the following syndrome scales: Emotionally Reactive, Anxious/Depressed, Somatic Complaints, Withdrawn, Attention Problems, Aggressive Behavior, and Sleep Problems.
Parents/caregivers rate each item 0=not true, 1=somewhat or sometimes true, 2=very true or often true of the child (based on the preceding two months).
Higher scores are correlated with more psychiatric symptoms.
|
3 months
|
Child Psychiatric Symptoms at 12 months
Time Frame: 12 months
|
The Child Behavior Checklist 1.5-5 (CBCL 1.5/5) will be used to assess child psychiatric symptoms which obtains caregivers' ratings of 99 problem items.
Items are scored on the following syndrome scales: Emotionally Reactive, Anxious/Depressed, Somatic Complaints, Withdrawn, Attention Problems, Aggressive Behavior, and Sleep Problems.
Parents/caregivers rate each item 0=not true, 1=somewhat or sometimes true, 2=very true or often true of the child (based on the preceding two months).
Higher scores are correlated with more psychiatric symptoms.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Unmet Social Needs Outcomes
Time Frame: Baseline, 3 months, 6 months, 12 months
|
Family unmet Social Needs Access, Utilization, and Adequacy of Resources will be measured using items from the Children's Health Watch Vital Signs and National Survey of Children's Health pertaining to all unmet needs in the PRECARE Screener.
|
Baseline, 3 months, 6 months, 12 months
|
Adverse Childhood Experiences
Time Frame: baseline and 12 months
|
The Adverse Childhood Experiences (CYW ACE-Q) Questionnaire will be used to measure cumulative child exposure to 17 stressful or traumatic events including abuse, neglect, and household dysfunction, as reported by the parent.
Higher scores are correlated with more adverse childhood experiences.
|
baseline and 12 months
|
Parental Depression
Time Frame: baseline, 3 months, 6 months, 12 months
|
Patient Health Questionnaire (PHQ)-9 will be used to measure frequency and severity of parental symptoms of depression within the past two weeks.
The measure is the major depressive disorder (MDD) module of the full PHQ, and scores each of the 9 DSM criteria of MDD as "0" (not at all) to "3" (nearly every day), providing a 0-27 severity score.
Higher scores are correlated with more parental depression.
|
baseline, 3 months, 6 months, 12 months
|
Parental Attention-deficit/hyperactivity disorder (ADHD)
Time Frame: baseline, 3 months, 6 months, 12 months
|
Adult ADHD Self-Report Scale (ASRS-v1.1)
Symptom Checklist will be used to measure parent ADHD symptoms.
The measure consists of 18 items matching DSM-IV criteria found to be the most predictive of symptoms consistent with adult ADHD.
Items are scored on a 5-point Likert scale, from Never to Very Often.
Higher scores are correlated with more parental ADHD symptoms.
|
baseline, 3 months, 6 months, 12 months
|
Global Perceived Stress
Time Frame: baseline, 3 months, 6 months, 12 months
|
The Perceived Stress Scale (PSS) will be used to measure perceptions of levels of stress within the past month using 10 items on a 4 point Likert scale indicating 0 = Never, 1 = Almost Never, 2 = Sometimes, 3 = Fairly Often, and 4 = Very Often.
Higher scores [range 0 to 40] are correlated with more perceived stress.
|
baseline, 3 months, 6 months, 12 months
|
Parenting Stress
Time Frame: baseline, 3 months, 6 months, 12 months
|
The Parenting Stress Inventory, Short Form (PSI-4-SF) will be used to measure specific levels of stress in relation to taking care of their child and the parent-child system, using a 4-point Likert scale from Strongly Disagree to Strongly Agree.
Higher scores are correlated with more parental stress.
|
baseline, 3 months, 6 months, 12 months
|
PRE-CARE Feasibility and Acceptability Questionnaire
Time Frame: 3 months
|
The PRE-CARE Feasibility and Acceptability Questionnaire will be used to measure intervention satisfaction using 14 items on a 4 point Likert scale.
Items will ask about satisfaction of information and resources provided, length of intervention, perceived helpfulness of intervention, and whether or not they would recommend the program to a parent of a similarly aged child.
Higher scores are correlate with greater satisfaction.
|
3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Andrea Spencer, MD, Boston Medical Center, Psychiatry Department
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-41211
- 5K23MH118478-03 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit/Hyperactivity Disorder
-
Cingulate TherapeuticsRecruitingPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcActive, not recruitingADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Children's National Research InstituteRecruitingADHD | Attention Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder | Attention Deficit Disorder | ADD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - Impulsive | Attention-Deficit Disorder in Adolescence | Attention-Deficit Hyperactivity...United States
-
Fondation LenvalCompletedAttention Deficit Disorder With Hyperactivity | Attention Deficit Disorder Without HyperactivityFrance
-
University Hospital Bispebjerg and FrederiksbergMental Health Services in the Capital Region, DenmarkRecruitingSleep Disturbance | Neurodevelopmental Disorders | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder | Attention-Deficit Hyperactivity Disorder, Unspecified Type | Attention-deficit Hyperactivity | Hyperkinetic Conduct DisorderDenmark
-
Corium, Inc.Worldwide Clinical Trials; Premier Research Group plc; Almac; Prometrika, LLCRecruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Corium, Inc.Premier Research Group plc; Almac; Prometrika, LLCActive, not recruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Massachusetts General HospitalShire Human Genetic Therapies, Inc.Active, not recruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Atatürk UniversityCompletedAttention-deficit/Hyperactivity DisorderTurkey
Clinical Trials on Screening
-
Vastra Gotaland RegionRecruiting
-
University of FloridaPatient-Centered Outcomes Research InstituteEnrolling by invitation
-
Peking University People's HospitalSun Yat-sen University; Fudan University; Sun Yat-Sen Memorial Hospital of Sun... and other collaboratorsCompletedBreast Cancer | Bone MetastasesChina
-
National Institute of Allergy and Infectious Diseases...Ohio Department of Health, City of Cincinnati Board of HealthCompleted
-
University of British ColumbiaUniversity of SydneyRecruitingCardiovascular Diseases | End Stage Renal Disease | Kidney Transplantation | Dialysis Related ComplicationCanada, United States, United Kingdom, Germany
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
University of La LagunaCompletedHepatitis C Virus InfectionSpain
-
LMC Diabetes & Endocrinology Ltd.RecruitingType 2 Diabetes | Nonalcoholic SteatohepatitisCanada
-
The University of Hong KongCompleted
-
University of PittsburghNational Institute of Mental Health (NIMH); Kaiser Foundation Research InstituteCompleted